NewsBite analysis · HealthTech, Startups · New Product
TechRadar
Whoop opens blood-testing and cancer screening service to non-Whoop owners
Whoop has announced that its blood-testing and cancer screening services are now accessible to users who do not have the Whoop fitness tracker. This strategic move allows consumers using rival brands, such as Garmin and Apple, to utilize Whoop's diagnostic test for USD 150, which includes new early cancer screening features. This initiative could significantly broaden Whoop's market reach and appeal to health-conscious individuals with various wearable devices.
MonitorConfidence: HighShort term horizon
Published 20 Aug 2026, 12:30 UTC1 min read
Visit original article ↗Lead image — TechRadar
Summary
TL;DR
- Whoop's blood-testing service expands to non-owners.
- Diagnostic test priced at USD 150.
- Includes new early cancer screening features.
- Available to users of Garmin and Apple devices.
- Aims to increase accessibility in health diagnostics.
Interesting facts
- The inclusion of cancer screening may distinguish Whoop's service from traditional fitness tracking.
- This move taps into a growing trend of health diagnostics beyond device ownership.
What changed
Whoop's blood-testing service is now available to users without requiring ownership of their device.